Morgan Stanley (LUNG) reports 6.9% Pulmonx stake in updated ownership filing

Rhea-AI Filing Summary

Morgan Stanley and Morgan Stanley Capital Services LLC report their beneficial ownership of Pulmonx Corp common stock on an amended Schedule 13G. Morgan Stanley reports 2,920,241 shares beneficially owned, representing 6.9% of the common stock, with 0 shares held with sole voting or dispositive power and the position held with shared voting and dispositive power. Morgan Stanley Capital Services LLC reports 2,885,147 shares, representing 6.8%, all with shared voting and dispositive power and none with sole power. The ownership is attributed to specified Morgan Stanley reporting units, and does not include securities held by disaggregated operating units under SEC Release No. 34-39538.

Key Figures

Morgan Stanley beneficial ownership: 2,920,241 shares Morgan Stanley percent of class: 6.9% Morgan Stanley shared voting power: 2,888,144 shares +5 more

8 metrics

Morgan Stanley beneficial ownership 2,920,241 shares Beneficially owned Pulmonx common stock; represents 6.9% of the class

Morgan Stanley percent of class 6.9% Percent of Pulmonx common stock class beneficially owned by Morgan Stanley

Morgan Stanley shared voting power 2,888,144 shares Pulmonx shares over which Morgan Stanley has shared voting power

Morgan Stanley shared dispositive power 2,920,241 shares Pulmonx shares over which Morgan Stanley has shared dispositive power

MS Capital Services beneficial ownership 2,885,147 shares Pulmonx common stock beneficially owned by Morgan Stanley Capital Services LLC

MS Capital Services percent of class 6.8% Percent of Pulmonx common stock class owned by Morgan Stanley Capital Services LLC

MS Capital Services shared voting power 2,885,147 shares Pulmonx shares over which Morgan Stanley Capital Services LLC has shared voting power

MS Capital Services shared dispositive power 2,885,147 shares Pulmonx shares over which Morgan Stanley Capital Services LLC has shared dispositive power

Key Terms

beneficially owned, shared voting power, shared dispositive power, parent holding company, +2 more

6 terms

beneficially owned financial

"this filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

shared voting power financial

"Shared Voting Power 2,888,144.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

shared dispositive power financial

"Shared Dispositive Power 2,920,241.00"

parent holding company financial

"Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company"

Joint Filing Agreement regulatory

"EXHIBIT NO. EXHIBITS 99.1 Joint Filing Agreement"

disaggregated financial

"ownership of securities is disaggregated from that of the MS Reporting Units in accordance with the Release"

FAQ

What ownership stake in Pulmonx Corp (LUNG) does Morgan Stanley report?

Morgan Stanley reports beneficial ownership of 2,920,241 Pulmonx Corp common shares, representing 6.9% of the class. These shares are held with shared voting and dispositive power through certain Morgan Stanley reporting units.

How many Pulmonx (LUNG) shares does Morgan Stanley Capital Services LLC hold?

Morgan Stanley Capital Services LLC reports beneficial ownership of 2,885,147 Pulmonx common shares, equal to 6.8% of the class. All reported shares are held with shared voting and shared dispositive power, and none with sole power.

Does Morgan Stanley have sole voting power over Pulmonx (LUNG) shares?

Morgan Stanley reports 0 shares of Pulmonx common stock with sole voting or sole dispositive power. All reported holdings are subject to shared voting and shared dispositive power as detailed on the cover pages.

What is the significance of the 6.9% ownership reported in Pulmonx (LUNG)?

The filing states Morgan Stanley beneficially owns 6.9% of Pulmonx’s common stock, or 2,920,241 shares. Crossing 5% triggers Schedule 13G reporting, so this reflects a large institutional position in the company’s equity.

Which Morgan Stanley units are included in this Pulmonx (LUNG) 13G/A filing?

The filing covers securities beneficially owned, or deemed beneficially owned, by certain Morgan Stanley operating units referred to as the “MS Reporting Units.” It explicitly excludes units whose holdings are disaggregated under SEC Release No. 34-39538.

Who signed the Pulmonx (LUNG) Schedule 13G/A on behalf of Morgan Stanley?

The Schedule 13G/A is signed by Claire Gordon as Authorized Signatory for both Morgan Stanley and Morgan Stanley Capital Services LLC, with signature dates of 08/13/2026 for each reporting person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/13/2026 - 05:28 PM Accepted by SEC EDGAR 08/13/2026 - 05:28 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 5)

Pulmonx Corp

(Name of Issuer)

Common Stock

(Title of Class of Securities)

745848101

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 745848101

1

Names of Reporting Persons

Morgan Stanley

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,888,144.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,920,241.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,920,241.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.9 %

12

Type of Reporting Person (See Instructions)

HC, CO

SCHEDULE 13G

CUSIP Number(s): 745848101

1

Names of Reporting Persons

Morgan Stanley Capital Services LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,885,147.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,885,147.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,885,147.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.8 %

12

Type of Reporting Person (See Instructions)

BD, CO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Pulmonx Corp
(b)	Address of issuer's principal executive offices: 700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
Item 2.
(a)	Name of person filing: 1: Morgan Stanley 2: Morgan Stanley Capital Services LLC
(b)	Address or principal business office or, if none, residence: 1: 1585 Broadway, New York, NY 10036 ;2: 1585 Broadway, New York, NY 10036
(c)	Citizenship: 1: Delaware 2: Delaware
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 745848101
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See the response(s) to Item 9 on the attached cover page(s).
(b)	Percent of class: 6.9 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See the response(s) to Item 5 on the attached cover page(s).
	(ii) Shared power to vote or to direct the vote: See the response(s) to Item 6 on the attached cover page(s).
	(iii) Sole power to dispose or to direct the disposition of: See the response(s) to Item 7 on the attached cover page(s).
	(iv) Shared power to dispose or to direct the disposition of: See the response(s) to Item 8 on the attached cover page(s).
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Exhibit 99.2
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. * In Accordance with the Securities and Exchange Commission Release No. 34-39538 (January 12, 1998) (the "Release"), this filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by certain operating units (collectively, the "MS Reporting Units") of Morgan Stanley and its subsidiaries and affiliates (collectively, "MS"). This filing does not reflect securities, if any, beneficially owned by any operating units of MS whose ownership of securities is disaggregated from that of the MS Reporting Units in accordance with the Release.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Morgan Stanley

Signature:	Claire Gordon
Name/Title:	Authorized Signatory, Morgan Stanley
Date:	08/13/2026

Morgan Stanley Capital Services LLC

Signature:	Claire Gordon
Name/Title:	Authorized Signatory, Morgan Stanley Capital Services LLC
Date:	08/13/2026

Exhibit Information

EXHIBIT NO. EXHIBITS ------------------ ------------------------------------ 99.1 Joint Filing Agreement 99.2 Item 7 Information * Attention. Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001).